The National Agency for Food and Drug Administration and Control, NAFDAC, has approved the use of AstraZeneca COVID-19 Vaccine in Nigeria.
The agency explained its vaccine committee expedited the review of the AstraZeneca vaccine based on the EUL given by the World Health Organization (WHO) on the 15th of February, 2021.
The Director General of NAFDAC, Prof Mojisola Adeyeye, who disclosed this at a press conference held in Abuja, said the agency received a dosage of the Vaccine a week ago and immediately went into action to check its efficacy and safety for Nigerians.
Adeyeye, said they were three additional vaccines undergoing evaluations and 30 herbal medicines undergoing review for listing.
The NAFDAC Boss said Nigeria stands in a better position to battle Covid-19.
According to her, the evaluation on the Astrazeneca vaccine shows that it is effective against the United Kingdom Variant of the Virus which has been reported in Nigeria.
She also affirmed that the vaccines could be stored in two to eight degrees Centigrade.
The NAFDAC DG stressed that the South African variant has not been reported in Nigeria.
She added that the Agency plans to use the Traceability with GS1 technology to monitor the vaccine distribution using Global Trade Item Number (GTIN).
She said it is to prevent fake vaccines from infiltrating the supply chain and to ensure there is no diversion. This effort will create a reliable and predictable supply chain
The Agency will be using its recently launched Med Safety App for Active Pharmacovigilance of the vaccines in collaboration with the sister agencies.
Adeyeye added that the App is free, and millions of healthcare workers can download it free for Adverse Drug Reaction (ADR) reporting.